MEDP - Company ID 0001668397
Medpace Holdings, Inc. trades as MEDP and has a market capitalization of $15.24 B, making it the #732 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $2.53B, up 20.0% from the prior year and net income of $451.12M. This page tracks Medpace Holdings, Inc. through 874 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
2026-07-09
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Over the last 9 fiscal years Medpace Holdings, Inc.'s revenue grew from $421.58M to $2.53B, a compound annual growth rate of 22.0%. Net profit margin expanded from 3.2% to 17.8% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Major company event | 8-K | 2026-05-19 |
| Insider trade | 4 | 2026-05-18 |
| Insider trade | 4 | 2026-05-18 |
| Insider trade | 4 | 2026-05-18 |
| Insider trade | 4 | 2026-05-18 |
| Insider trade | 4 | 2026-05-18 |
| Insider trade | 4 | 2026-05-18 |
| Insider trade | 4 | 2026-04-28 |
Medpace Holdings, Inc. Reports First Quarter 2026 Results | Medpace Holdings, Inc.
Our mission is to accelerate the development of safe and effective medical therapeutics.
Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Results | Medpace Holdings, Inc.
Our mission is to accelerate the development of safe and effective medical therapeutics.
(Nasdaq: MEDP) (“Medpace”) today announced that it will report its first quarter 2026 financial results after the market close on Wednesday, April 22, 2026 .
The largest companies sharing Medpace Holdings, Inc.'s SEC industry classification (services-commercial physical & biological research).
Medpace Holdings, Inc. (MEDP) has a market capitalization of $15.24 B as of 2026-07-09, ranking #732 among US-listed companies.
Medpace Holdings, Inc. reported revenue of $2.53B for fiscal year 2025, an increase of 20.0% year over year.
Yes. Medpace Holdings, Inc. reported net income of $451.12M in its latest fiscal year.